New York Senate Bill 2625: Allows a licensed pharmacist to prescribe and order FDA-approved medication assisted therapy under a non-patient-specific regimen for the treatment of opioid use disease.

New York · 2025-2026 session

What it does

Allows a licensed pharmacist to prescribe and order FDA-approved medication assisted therapy under a non-patient-specific regimen for the treatment of opioid use disease.

Latest action

REPORTED AND COMMITTED TO HIGHER EDUCATION (2026-03-17)

See how S 2625 affects you on CapitolKey

Browse more bills · CapitolKey home